NextCure shareholders reject officer exculpation amendment at 2024 annual meeting

NextCure, Inc.

Proposal to amend charter to exculpate officers failed: 10,638,433 for, 2,863,486 against, 11,212 abstain.
Elaine V. Jones and Ellen G. Feigal elected as Class II directors with 11.8M and 12.9M votes for, respectively.
Ernst & Young LLP ratified as independent auditor for FY2024: 21,818,499 for, 98,189 against.
Broker non-votes of 8,403,929 on director election and exculpation proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.